MPM BioImpact LLC Diversified Active

CIK: 0001687078 · Show all filings

Period: Q4 2020 (← Previous) (Next →)

Filing Date: Feb 24, 2021

Total Value ($000): $588,506 (100.0% shares, 0.0% debt)

Holdings (16)

— TCR2 Therapeutics, Inc. 17.7%

Value ($000) $104,264 Shares 3,370,982 Est. Cost $14.28 Unrealized —

— Repare Therapeutics, Inc. 13.9%

Value ($000) $81,920 Shares 2,388,337 Est. Cost $31.02 Unrealized —

— iTeos Therapeutics, Inc. 13.5%

Value ($000) $79,665 Shares 2,355,557 Est. Cost $24.67 Unrealized —

— Oncorus, Inc. 13.1%

Value ($000) $76,849 Shares 2,377,031 Est. Cost $32.33 Unrealized —

— Harpoon Therapeutics, Inc. 11.0%

Value ($000) $64,753 Shares 3,898,422 Est. Cost $14.79 Unrealized —

— Turning Point Therapeutics, Inc. 6.4%

Value ($000) $37,613 Shares 308,686 Est. Cost $44.66 Unrealized —

— Epizyme, Inc. 5.3%

Value ($000) $31,002 Shares 2,854,737 Est. Cost $22.28 Unrealized —

— MEI Pharma, Inc. 4.5%

Value ($000) $26,764 Shares 10,137,859 Est. Cost $3.11 Unrealized —

— G1 Therapeutics, Inc. 4.4%

Value ($000) $25,614 Shares 1,423,794 Est. Cost $26.43 Unrealized —

ADCT ADC Therapeutics, Inc. 2.9%

Value ($000) $17,274 Shares 539,648 Est. Cost $38.22 Unrealized -14.3%

— YmAbs Therapeutics, Inc. 2.8%

Value ($000) $16,699 Shares 337,291 Est. Cost $31.25 Unrealized —

— Merus N.V. 2.1%

Value ($000) $12,286 Shares 700,879 Est. Cost $16.09 Unrealized —

NTLA Intellia Therapeutics, Inc. 1.2%

Value ($000) $6,972 Shares 128,162 Est. Cost $36.31 Unrealized 0.0%

— AVROBIO, Inc. 0.9%

Value ($000) $5,078 Shares 364,285 Est. Cost $13.94 Unrealized —

BDTX Black Diamond Therapeutcs, Inc. 0.2%

Value ($000) $1,398 Shares 43,615 Est. Cost $32.85 Unrealized 0.0%

AUTL Autolus Therapeutics Limited 0.1%

Value ($000) $355 Shares 39,740 Est. Cost $13.21 Unrealized —

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
—	TCR2 Therapeutics, Inc.	3,370,982	$104,264	17.7%	$14.28	—	Common	87808K106
—	Repare Therapeutics, Inc.	2,388,337	$81,920	13.9%	$31.02	—	Common	760273102
—	iTeos Therapeutics, Inc.	2,355,557	$79,665	13.5%	$24.67	—	Common	46565G104
—	Oncorus, Inc.	2,377,031	$76,849	13.1%	$32.33	—	Common	68236R103
—	Harpoon Therapeutics, Inc.	3,898,422	$64,753	11.0%	$14.79	—	Common	41358P106
—	Turning Point Therapeutics, Inc.	308,686	$37,613	6.4%	$44.66	—	Common	90041T108
—	Epizyme, Inc.	2,854,737	$31,002	5.3%	$22.28	—	Common	29428V104
—	MEI Pharma, Inc.	10,137,859	$26,764	4.5%	$3.11	—	Common	552798202
—	G1 Therapeutics, Inc.	1,423,794	$25,614	4.4%	$26.43	—	Common	3621LQ109
ADCT	ADC Therapeutics, Inc.	539,648	$17,274	2.9%	$38.22	-14.3%	Common	H0036K147
—	YmAbs Therapeutics, Inc.	337,291	$16,699	2.8%	$31.25	—	Common	984241109
—	Merus N.V.	700,879	$12,286	2.1%	$16.09	—	Common	N5749R100
NTLA	Intellia Therapeutics, Inc.	128,162	$6,972	1.2%	$36.31	0.0%	Common	45826J105
—	AVROBIO, Inc.	364,285	$5,078	0.9%	$13.94	—	Common	05455M100
BDTX	Black Diamond Therapeutcs, Inc.	43,615	$1,398	0.2%	$32.85	0.0%	Common	09203E105
AUTL	Autolus Therapeutics Limited	39,740	$355	0.1%	$13.21	—	Common	05280R100